Skip to main content

Advertisement

Log in

Bioactive Moringa olifera seed extracts attenuates cholesterol gall stones in hyperglycaemic Swiss mice

  • Original Article
  • Published:
Comparative Clinical Pathology Aims and scope Submit manuscript

Abstract

Gallstones (cholelithiasis) are thickened components of the lipid-modulating digestive fluid in the gall bladder. Commonly, cholesterol super saturation from excess cholesterol or inadequate solubilizing bile salts may result in cholesterol gall stone formation, while excess bilirubin because of liver damage or blood disorders may form pigment gallstones. Cholesterol gall stone formation is strongly correlated with diabetes mellitus and both diseases predispose patients to a high hospitalization rate. Recent studies have examined the potential of Moringa oleifera as a functional food, highlighting the need to test different parts of the deciduous tree for its treatment or adjuvant efficacy. In this study, we report the gall bladder cytoprotective ability of Moringa oleifera seed extracts and the hepatoprotective potential of the seed cake in hyperglycemic and cholesterol gall stone-induced Swiss mice. We show that the seed cake contains 37% protein and caused a 40% increase in body weight over 5 weeks, but the seed oil caused only a 15% increase in body weight over the same period, which supports the possible use of the seed oil as a functional food for weight loss. Seed cake treatment presented the potential for glycemic control, improved hematological and lipid profile and enhanced liver antioxidant activity. Seed oil increased blood high density lipoprotein content, and all seed extracts reduced hepatic sodium pump activity. Our results highlight the need to extract the active compounds in functional foods, as against using the whole plant parts as adjuvant therapies, and it makes a case for the antihyperglycemic and cytoprotective efficacy of Moringa oleifera seed extracts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

All data used are available upon reasonable request made to the corresponding author.

Materials availability

All materials used are available upon reasonable request made to the corresponding author.

Code availability

Not applicable.

References

Download references

Funding

This work is self-funded.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Olawande C. Olagoke.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Ethics approval

Requisite approval (UI-ACUREC/19/005) was gotten from the Animal Care and Use Research Ethics Committee of the University of Ibadan.

Consent to participate

Not applicable.

Consent for publication

The authors grant Comparative Clinical Pathology the appropriate consent to publish this work.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salami, A.T., Okonkwo, C.E., Attah, F.A. et al. Bioactive Moringa olifera seed extracts attenuates cholesterol gall stones in hyperglycaemic Swiss mice. Comp Clin Pathol 30, 207–216 (2021). https://doi.org/10.1007/s00580-021-03206-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00580-021-03206-3

Keywords

Navigation